Currently, liver ultrasound examination and serum alpha-fetoprotein (AFP) analysis are recommended to screen patients with early-stage HCC [3]; however, both of these techniques lack sufficient sensitivity to detect early lesions. Here, AFP is linked to hepatocellular carcinoma.